Integer (NYSE:ITGR - Get Free Report) had its price objective hoisted by equities researchers at Truist Financial from $147.00 to $163.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has a "buy" rating on the medical equipment provider's stock. Truist Financial's target price would indicate a potential upside of 15.98% from the stock's previous close.
Several other brokerages also recently commented on ITGR. Wells Fargo & Company reaffirmed an "overweight" rating and set a $160.00 price objective on shares of Integer in a research note on Tuesday, December 3rd. Piper Sandler reiterated an "overweight" rating and issued a $140.00 price objective (up from $125.00) on shares of Integer in a research report on Friday, October 25th. Bank of America raised their target price on shares of Integer from $135.00 to $145.00 and gave the stock a "buy" rating in a report on Tuesday, October 1st. Citigroup upped their price target on shares of Integer from $124.00 to $130.00 and gave the company a "neutral" rating in a report on Tuesday, October 1st. Finally, KeyCorp raised their price objective on shares of Integer from $139.00 to $144.00 and gave the stock an "overweight" rating in a report on Tuesday, October 15th. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $145.44.
Check Out Our Latest Stock Analysis on ITGR
Integer Trading Up 0.6 %
ITGR traded up $0.90 during trading on Wednesday, reaching $140.54. 167,307 shares of the company's stock were exchanged, compared to its average volume of 304,207. The company's fifty day moving average price is $133.32 and its 200-day moving average price is $125.51. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. The firm has a market capitalization of $4.71 billion, a PE ratio of 43.38, a P/E/G ratio of 2.00 and a beta of 1.12. Integer has a fifty-two week low of $92.54 and a fifty-two week high of $142.76.
Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, beating analysts' consensus estimates of $1.36 by $0.07. The business had revenue of $431.42 million during the quarter, compared to the consensus estimate of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. The firm's revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.27 earnings per share. As a group, equities analysts forecast that Integer will post 5.33 EPS for the current year.
Institutional Inflows and Outflows
Several institutional investors have recently made changes to their positions in the stock. Blue Trust Inc. raised its holdings in shares of Integer by 460.4% in the 2nd quarter. Blue Trust Inc. now owns 5,643 shares of the medical equipment provider's stock valued at $658,000 after purchasing an additional 4,636 shares during the period. Loomis Sayles & Co. L P raised its stake in Integer by 3.0% in the third quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider's stock valued at $69,943,000 after buying an additional 15,446 shares during the period. Earnest Partners LLC lifted its position in shares of Integer by 3.2% in the second quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider's stock valued at $139,911,000 after buying an additional 37,340 shares during the last quarter. Great Lakes Advisors LLC boosted its stake in shares of Integer by 56.7% during the 2nd quarter. Great Lakes Advisors LLC now owns 45,218 shares of the medical equipment provider's stock worth $5,236,000 after acquiring an additional 16,355 shares during the period. Finally, SG Americas Securities LLC acquired a new position in shares of Integer during the 3rd quarter worth approximately $651,000. Institutional investors and hedge funds own 99.29% of the company's stock.
Integer Company Profile
(
Get Free Report)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Featured Articles
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.